Lone Pine Capital Has Lowered By $186.13 Million Its Activision Blizzard (ATVI) Holding; Tocqueville Asset Management LP Increased Its Sage Therapeutics (SAGE) Position

November 15, 2017 - By Richard Conner

Lone Pine Capital Llc decreased Activision Blizzard Inc (ATVI) stake by 13.17% reported in 2017Q2 SEC filing. Lone Pine Capital Llc sold 3.27 million shares as Activision Blizzard Inc (ATVI)’s stock rose 23.27%. The Lone Pine Capital Llc holds 21.54 million shares with $1.24B value, down from 24.80 million last quarter. Activision Blizzard Inc now has $48.41 billion valuation. The stock declined 1.28% or $0.82 reaching $63.21 per share. About 19,227 shares traded. Activision Blizzard, Inc. (NASDAQ:ATVI) has risen 47.83% since November 15, 2016 and is uptrending. It has outperformed by 31.13% the S&P500.

Tocqueville Asset Management Lp increased Sage Therapeutics Inc (SAGE) stake by 17.04% reported in 2017Q2 SEC filing. Tocqueville Asset Management Lp acquired 10,400 shares as Sage Therapeutics Inc (SAGE)’s stock rose 0.86%. The Tocqueville Asset Management Lp holds 71,450 shares with $5.69 million value, up from 61,050 last quarter. Sage Therapeutics Inc now has $3.31 billion valuation. The stock declined 2.10% or $1.85 reaching $86.4 on the news. About 28,175 shares traded. SAGE Therapeutics Inc (NASDAQ:SAGE) has risen 116.45% since November 15, 2016 and is uptrending. It has outperformed by 99.75% the S&P500.

Investors sentiment decreased to 0.98 in Q2 2017. Its down 0.13, from 1.11 in 2017Q1. It dived, as 24 investors sold SAGE shares while 61 reduced holdings. 30 funds opened positions while 53 raised stakes. 37.20 million shares or 2.18% more from 36.41 million shares in 2017Q1 were reported. Rhumbline Advisers reported 41,138 shares. Alps Incorporated has invested 0.02% of its portfolio in SAGE Therapeutics Inc (NASDAQ:SAGE). Massachusetts-based Loring Wolcott And Coolidge Fiduciary Ltd Liability Partnership Ma has invested 0% in SAGE Therapeutics Inc (NASDAQ:SAGE). Moreover, Great Point Ltd Llc has 3.48% invested in SAGE Therapeutics Inc (NASDAQ:SAGE). Bnp Paribas Arbitrage owns 4,296 shares. Manufacturers Life Insurance The has invested 0% of its portfolio in SAGE Therapeutics Inc (NASDAQ:SAGE). Ghost Tree Capital Limited has invested 0.83% in SAGE Therapeutics Inc (NASDAQ:SAGE). Metropolitan Life Ins New York invested in 23,452 shares or 0.01% of the stock. Prudential Finance reported 0% of its portfolio in SAGE Therapeutics Inc (NASDAQ:SAGE). Alliancebernstein Ltd Partnership reported 0.04% of its portfolio in SAGE Therapeutics Inc (NASDAQ:SAGE). 100 were accumulated by Creative Planning. Blackrock holds 3.03 million shares. Grp One Trading Lp has 0.01% invested in SAGE Therapeutics Inc (NASDAQ:SAGE) for 7,412 shares. Wells Fargo Mn reported 74,723 shares. Lazard Asset Mngmt Limited Company holds 0% or 25,500 shares.

Among 16 analysts covering SAGE Therapeutics (NASDAQ:SAGE), 14 have Buy rating, 0 Sell and 2 Hold. Therefore 88% are positive. SAGE Therapeutics had 42 analyst reports since September 3, 2015 according to SRatingsIntel. The stock has “Buy” rating by Needham on Tuesday, September 12. Cowen & Co maintained SAGE Therapeutics Inc (NASDAQ:SAGE) on Tuesday, September 12 with “Buy” rating. The stock of SAGE Therapeutics Inc (NASDAQ:SAGE) earned “Buy” rating by Leerink Swann on Tuesday, June 20. The stock of SAGE Therapeutics Inc (NASDAQ:SAGE) earned “Outperform” rating by Raymond James on Tuesday, September 13. Stifel Nicolaus maintained the stock with “Buy” rating in Tuesday, September 12 report. The firm has “Buy” rating given on Tuesday, June 13 by Needham. The rating was maintained by RBC Capital Markets with “Buy” on Monday, October 16. The stock of SAGE Therapeutics Inc (NASDAQ:SAGE) earned “Buy” rating by Cowen & Co on Thursday, November 9. The firm has “Outperform” rating given on Wednesday, June 29 by BMO Capital Markets. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, September 12.

Tocqueville Asset Management Lp decreased Barnes Group Inc. (NYSE:B) stake by 25,000 shares to 116,975 valued at $6.85M in 2017Q2. It also reduced Mcdonald’s Corp. (NYSE:MCD) stake by 4,242 shares and now owns 387,013 shares. Mag Silver Corp (NYSEMKT:MVG) was reduced too.

Investors sentiment increased to 1.15 in 2017 Q2. Its up 0.24, from 0.91 in 2017Q1. It is positive, as 53 investors sold ATVI shares while 215 reduced holdings. 98 funds opened positions while 210 raised stakes. 639.89 million shares or 1.59% less from 650.21 million shares in 2017Q1 were reported. Strs Ohio reported 1.60 million shares or 0.41% of all its holdings. Gsa Cap Partners Llp has invested 0.2% of its portfolio in Activision Blizzard, Inc. (NASDAQ:ATVI). Moreover, Advisory Services Net Limited Liability has 0.08% invested in Activision Blizzard, Inc. (NASDAQ:ATVI). Tru Of Vermont invested in 29,008 shares or 0.17% of the stock. Proshare Advsr Llc owns 0.17% invested in Activision Blizzard, Inc. (NASDAQ:ATVI) for 294,679 shares. Geode Cap Mngmt Ltd Limited Liability Company holds 6.80M shares or 0.15% of its portfolio. Earnest Prtn Limited Liability Company holds 794,960 shares or 0.48% of its portfolio. Lpl Fincl Ltd Co invested 0.02% of its portfolio in Activision Blizzard, Inc. (NASDAQ:ATVI). Whittier holds 130,316 shares or 0.29% of its portfolio. Old Mutual Customised Solutions (Proprietary) Ltd invested in 11,769 shares. Voya Invest Management Ltd Company accumulated 0.27% or 2.06M shares. Fil holds 0.47% or 2.83 million shares in its portfolio. Jericho Asset Mgmt LP has invested 2.9% in Activision Blizzard, Inc. (NASDAQ:ATVI). Barometer Cap Management holds 0.83% or 142,750 shares. L And S Advsr stated it has 0.13% in Activision Blizzard, Inc. (NASDAQ:ATVI).

Analysts await Activision Blizzard, Inc. (NASDAQ:ATVI) to report earnings on February, 8. They expect $0.86 EPS, 0.00% or $0.00 from last year’s $0.86 per share. ATVI’s profit will be $658.64 million for 18.38 P/E if the $0.86 EPS becomes a reality. After $0.43 actual EPS reported by Activision Blizzard, Inc. for the previous quarter, Wall Street now forecasts 100.00% EPS growth.

Among 28 analysts covering Activision Blizzard (NASDAQ:ATVI), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Activision Blizzard has $82 highest and $29.51 lowest target. $60.28’s average target is -4.64% below currents $63.21 stock price. Activision Blizzard had 115 analyst reports since July 28, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of ATVI in report on Wednesday, December 14 with “Buy” rating. On Friday, November 4 the stock rating was maintained by Wedbush with “Outperform”. On Wednesday, October 11 the stock rating was maintained by Piper Jaffray with “Buy”. The firm has “Buy” rating by Brean Capital given on Wednesday, August 5. The rating was maintained by Robert W. Baird with “Buy” on Wednesday, August 23. The firm has “Buy” rating given on Friday, August 5 by Mizuho. The stock of Activision Blizzard, Inc. (NASDAQ:ATVI) earned “Buy” rating by UBS on Wednesday, August 5. The company was downgraded on Thursday, August 6 by Hilliard Lyons. The rating was maintained by Wedbush on Friday, February 12 with “Outperform”. The stock has “Buy” rating by Jefferies on Wednesday, August 5.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com